RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)
AssigneeMerck Sharp & Dohme Corp.
InventorsJames McSwiggen, Leonid Beigelman
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Sharp & Dohme Corp.
InventorsJames McSwiggen, Leonid Beigelman
Estimating the term…
This invention relates to compounds, compositions, and methods useful for modulating chemokine receptor (CXCR) gene expression using short interfering nucleic acid (siNA) molecules. This invention also relates to compounds, compositions, and methods useful for modulating the expression and activity of other genes involved in pathways of CXCR gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of CXCR genes such as CXCR4 and CXCR7A.
A chemically modified short interfering nucleic acid (siNA) molecule, wherein:
A chemically modified short interfering nucleic acid (siNA) molecule, wherein:
Dependencies are inferred from the claim text.